These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9241714)

  • 21. The prescription of peritoneal dialysis.
    Tzamaloukas AH; Raj DS; Onime A; Servilla KS; Vanderjagt DJ; Murata GH
    Semin Dial; 2008; 21(3):250-7. PubMed ID: 18248525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which mathematical model to study uremic toxicity? National Cooperative Dialysis Study.
    Sargent JA; Lowrie EG
    Clin Nephrol; 1982 Jun; 17(6):303-14. PubMed ID: 7049475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dialysis adequacy and nutritional status of hemodialysis patients.
    Teixeira Nunes F; de Campos G; Xavier de Paula SM; Merhi VA; Portero-McLellan KC; da Motta DG; de Oliveira MR
    Hemodial Int; 2008 Jan; 12(1):45-51. PubMed ID: 18271840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of improvement in adequacy of intermittent hemodialysis in uremic patients.
    Grzegorzewska AE; Banachowicz W; Leander M
    Rocz Akad Med Bialymst; 2005; 50():314-8. PubMed ID: 16358991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the behavior of phenols and creatinine in renal insufficiency, especilly in chronic dialysis patients].
    Jutzler GA; Kramer HJ; Keller HE; Kramer H; Doenecke F
    Arch Klin Med; 1968; 214(3):214-43. PubMed ID: 5683859
    [No Abstract]   [Full Text] [Related]  

  • 28. Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables.
    Recker RR; Saville PD
    J Lab Clin Med; 1971 Sep; 78(3):380-8. PubMed ID: 5092859
    [No Abstract]   [Full Text] [Related]  

  • 29. ["Clinical clearance" and "weekly clearance" of urea in periodical hemodialytic treatment].
    Ghezzi PM; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(39):2821-3. PubMed ID: 7432691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dose of dialysis in hemodialysis patients: impact on nutrition.
    Schulman G
    Semin Dial; 2004; 17(6):479-88. PubMed ID: 15660579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to the delivery of adequate hemodialysis in ESRD Network 4.
    Palevsky PM; Washington MS; Stevenson JA; Rohay JM; Dyer NJ; Lockett R; Perry SB
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S11-20. PubMed ID: 11053582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodialysis adequacy and quality of life: how do they relate?
    Hamilton G; Locking-Cusolito H
    CANNT J; 2003; 13(4):24-9. PubMed ID: 14753099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance.
    Twardowski ZJ
    Blood Purif; 2007; 25(1):90-8. PubMed ID: 17170543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 35. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?].
    Mandolfo S; Imbasciati E
    G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mathematical method based on urea kinetic modeling for computing the dialysis dose.
    Prado M; Roa L; Palma A; Milán JA
    Comput Methods Programs Biomed; 2004 May; 74(2):109-28. PubMed ID: 15013593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urea-oriented dialysis management in routine care].
    Remoli E; Stradtmann H; Gmyrek G
    Z Urol Nephrol; 1986 Apr; 79(5):295-307. PubMed ID: 3739439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A perspective on uremic toxins.
    Black DA
    Arch Intern Med; 1970 Nov; 126(5):906-9. PubMed ID: 5475716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.